Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Manufacturing (cGMP) deviations

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards.

1,754 FDA drug recalls with this cause, newest first.

This category covers departures from current Good Manufacturing Practice during production. It is FDA's broadest label, used when a facility's own process control failed somewhere along the line even if no single ingredient was proven unsafe on its own. Where the report names a specific consequence - a temperature excursion, a contaminant, a potency problem - we file the recall under that more specific cause instead; what remains here is the genuinely general case.

Class II · Moderate risk

Sucralfate Tablets

CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.

Ongoing cGMP deviation Nostrum Laboratories, Inc. NDC 29033-0003-01 D-0547-2025
Class II · Moderate risk

Peripheral Parenteral Nutrition

Lack of Processing Controls; prescriptions were compounded in an ISO-5 area where it was identified that a daily cleaning step was not sufficiently documented.

Ongoing cGMP deviation Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles D-0530-2025
Class II · Moderate risk

temper tamer

CGMP Deviations

Ongoing cGMP deviation Siddha Flower Essences, LLC. NDC 69779-020-01 D-0410-2025
Class II · Moderate risk

Nature Mint

CGMP Deviations

Terminated cGMP deviation Kenil Healthcare Private Limited NDC 53247-131-05 D-0440-2025
Class II · Moderate risk

Nature Mint

CGMP Deviations

Terminated cGMP deviation Kenil Healthcare Private Limited NDC 53247-131-07 D-0437-2025
Class II · Moderate risk

Nature Mint

CGMP Deviations

Terminated cGMP deviation Kenil Healthcare Private Limited NDC 53247-131-02 D-0436-2025
Class II · Moderate risk

Nature Mint

CGMP Deviations

Terminated cGMP deviation Kenil Healthcare Private Limited NDC 53247-131-06 D-0435-2025
Class II · Moderate risk

Maximum Security

CGMP Deviations

Terminated cGMP deviation Kenil Healthcare Private Limited NDC 53247-132-04 D-0434-2025
Class II · Moderate risk

Maximum Security

CGMP Deviations

Terminated cGMP deviation Kenil Healthcare Private Limited NDC 53247-132-01 D-0433-2025
Class II · Moderate risk

Maximum Security

CGMP Deviations

Terminated cGMP deviation Kenil Healthcare Private Limited NDC 53247-132-03 D-0432-2025
Class II · Moderate risk

Rapidol

CGMP Deviations

Terminated cGMP deviation Kenil Healthcare Private Limited NDC 55758-440-02 D-0429-2025